Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ, Chen YC, Huang YX, Zhao WC, Liu YH, Venkataramanan R, Lu BF, Li S. Sun JJ, et al. Among authors: Lu BF. Acta Pharmacol Sin. 2017 Jun;38(6):823-834. doi: 10.1038/aps.2017.44. Epub 2017 May 8. Acta Pharmacol Sin. 2017. PMID: 28504251 Free PMC article.
T-cell death and cancer immune tolerance.
Lu B, Finn OJ. Lu B, et al. Cell Death Differ. 2008 Jan;15(1):70-9. doi: 10.1038/sj.cdd.4402274. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007660 Review.
23 results
Jump to page
Feedback